---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-001640"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T08:50:05.554832+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Unicycive gets Nasdaq extension to July 7, 2025 to meet $1 bid price

## Summary
- Initial non-compliance notice received July 9, 2024; 180-day cure period ended Jan 6 without compliance.
- Nasdaq granted an additional 180 calendar days, until July 7, 2025, to regain $1.00 minimum bid.
- Company will monitor bid price and may consider options such as a reverse stock split if needed.

## SEC filing metadata
- accession: 0001213900-25-001640
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390025001640/0001213900-25-001640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025001640/ea0227071-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-001640
- JSON: https://secwatch.observer/filing/0001213900-25-001640.json
- Plain text: https://secwatch.observer/filing/0001213900-25-001640.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.